Heart failure in Hispanic patients: coming together?
Ventura
Hector O
HO
Department of Cardiology John Ochsner Heart and Vascular Institute, Ochsner Clinic Foundation, New Orleans, LA 70121, USA. hventura@ochsner.org
Piña
Ileana
I
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D001741:Black or African American / Q000706:statistics & numerical data; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy / Q000453:epidemiology*; D006630:Hispanic or Latino / Q000706:statistics & numerical data*; D006801:Humans; D012307:Risk Factors; D014481:United States / Q000453:epidemiology; D044465:White People / Q000706:statistics & numerical data
D000319:Adrenergic beta-Antagonists; D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents